Insider Trading History of Tombesi Paolo

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Tombesi Paolo since 2020. This trader's CIK number is 1707648. At the time of last reporting, Tombesi Paolo was the EVP & Chief Financial Officer of Turning Point Therapeutics, Inc.. (stock ticker symbol TPTX). Also see all insider trading activities at Turning Point Therapeutics, Inc..

Note that in the past TOMBESI PAOLO also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Turning Point Therapeutics, Inc. (TPTX) by Tombesi Paolo

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 TPTX 0 $0 1,183 $88,654 0 $0

Yearly summary of insider trading at Epizyme, Inc. (EPZM) by Tombesi Paolo

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 EPZM 0 $0 1,021 $11,445 0 $0
2020 EPZM 0 $0 3,048 $48,143 7,055 $0


Insider trading activities at 2 companies by Tombesi Paolo:

1. Turning Point Therapeutics, Inc. (TPTX)

2. Epizyme, Inc. (EPZM)

Table 1. Insider trading of Turning Point Therapeutics, Inc. (TPTX) by Tombesi Paolo

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-07-27 TPTX Sale 1,183 74.94 88,654

Table 2. Insider trading of Epizyme, Inc. (EPZM) by Tombesi Paolo

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-02-04 EPZM Sale 1,021 11.21 11,445
2020-08-19 EPZM Option Ex 7,055 .00 0
2020-06-26 EPZM Sale 1,805 16.15 29,150
2020-03-25 EPZM Sale 1,243 15.28 18,993

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Tombesi Paolo (EVP & Chief Financial Officer of Turning Point Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.